company background image
EPN logo

Epsilon Healthcare ASX:EPN Stock Report

Last Price

AU$0.024

Market Cap

AU$7.2m

7D

0%

1Y

20.0%

Updated

16 Mar, 2024

Data

Company Financials

Epsilon Healthcare Limited

ASX:EPN Stock Report

Market Cap: AU$7.2m

EPN Stock Overview

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. More details

EPN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Risk Analysis

Earnings have declined by 4.2% per year over past 5 years

Does not have a meaningful market cap (A$7M)

Shares are highly illiquid

Has less than 1 year of cash runway

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

Epsilon Healthcare Limited Competitors

Cann Global

ASX:CGB

AU$5.4m

Ecofibre

ASX:EOF

AU$10.2m

Avecho Biotechnology

ASX:AVE

AU$9.5m

Emyria

ASX:EMD

AU$15.0m

Price History & Performance

Summary of share price highs, lows and changes for Epsilon Healthcare
Historical stock prices
Current Share PriceAU$0.024
52 Week HighAU$0.034
52 Week LowAU$0.016
Beta0.92
1 Month Change0%
3 Month Change0%
1 Year Change20.00%
3 Year Change-89.57%
5 Year Change-95.60%
Change since IPO-94.07%

Recent News & Updates

Recent updates

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Oct 13
Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Jun 30
Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Sep 26
We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Jun 13
Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Feb 27
Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Shareholder Returns

EPNAU PharmaceuticalsAU Market
7D0%-4.9%-2.7%
1Y20.0%-9.3%6.5%

Return vs Industry: EPN underperformed the Australian Pharmaceuticals industry which returned 61.8% over the past year.

Return vs Market: EPN exceeded the Australian Market which returned 9.6% over the past year.

Price Volatility

Is EPN's price volatile compared to industry and market?
EPN volatility
EPN Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement10.3%
Market Average Movement8.0%
10% most volatile stocks in AU Market16.8%
10% least volatile stocks in AU Market3.1%

Stable Share Price: EPN has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine EPN's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2016n/aDaniel Sangheraepsilonhealthcare.com.au

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021.

Epsilon Healthcare Limited Fundamentals Summary

How do Epsilon Healthcare's earnings and revenue compare to its market cap?
EPN fundamental statistics
Market capAU$7.21m
Earnings (TTM)-AU$5.93m
Revenue (TTM)AU$7.21m

1.0x

P/S Ratio

-1.2x

P/E Ratio

Is EPN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EPN income statement (TTM)
RevenueAU$7.21m
Cost of RevenueAU$5.09m
Gross ProfitAU$2.12m
Other ExpensesAU$8.05m
Earnings-AU$5.93m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.02
Gross Margin29.46%
Net Profit Margin-82.17%
Debt/Equity Ratio27.1%

How did EPN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/03/16 03:55
End of Day Share Price 2023/12/18 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Epsilon Healthcare Limited is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution